• Eupraxia Pharmaceuticals will host a virtual analyst day on EP-104GI for eosinophilic esophagitis on November 13, 2026, at 8:30 a.m. ET.
• Management will join the Craig Hallum Biotech Catalyst Virtual Conference on October 22, 2026; fireside chat starts at 10:30 a.m. ET.
• BIO-Europe participation is scheduled for November 9-11, 2026, in Cologne, Germany, with one-on-one meetings.
• The Stifel 2026 Healthcare Conference runs November 10-12 in New York; management’s fireside chat is November 10 at 4:40 p.m. ET.
• A presentation at the Jefferies Global Healthcare Conference in London, November 16-19, 2026, is scheduled for November 16 at 1:30 p.m. GMT.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eupraxia Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610220830PRIMZONEFULLFEED9850901) on October 22, 2026, and is solely responsible for the information contained therein.